| Code | Display |
| specimen-satisfactory |
Specimen satisfactory for evaluation |
| specimen-limited |
Specimen satisfactory but limited |
| specimen-insufficient |
Insufficient tissue for diagnosis |
| treatment-unknown |
Treatment effect unknown |
| treatment-unidentifiable |
Treatment effect unidentifiable |
| treatment-radiotherapy |
Observed radiotherapy effect |
| treatment-hormone |
Observed hormone therapy effect |
| treatment-other |
Observed other therapy effect |
| hist-acinar |
Acinar adenocarcinoma (conventional) |
| hist-acinar-signet-ring |
Acinar adenocarcinoma, signet-ring cell-like |
| hist-acinar-pleomorphic |
Acinar adenocarcinoma, pleomorphic giant cell |
| hist-acinar-sarcomatoid |
Acinar adenocarcinoma, sarcomatoid |
| hist-acinar-pin-like |
Acinar adenocarcinoma, PIN-like |
| hist-idc-isolated |
Isolated intraductal carcinoma |
| hist-ductal |
Ductal adenocarcinoma |
| hist-adenosquamous |
Adenosquamous carcinoma |
| hist-squamous |
Squamous cell carcinoma |
| hist-basal-cell |
Basal cell (adenoid cystic) carcinoma |
| hist-neuro-adeno |
Adenocarcinoma with neuroendocrine differentiation |
| hist-neuro-well-diff |
Well-differentiated neuroendocrine tumor |
| hist-neuro-small-cell |
Small cell neuroendocrine carcinoma |
| hist-neuro-large-cell |
Large cell neuroendocrine carcinoma |
| hist-unassessable |
Carcinoma, type unassessable |
| hist-other |
Other histological type (see comment) |
| isup-gg1 |
ISUP Grade Group 1 (Gleason 3+3) |
| isup-gg2 |
ISUP Grade Group 2 (Gleason 3+4) |
| isup-gg3 |
ISUP Grade Group 3 (Gleason 4+3) |
| isup-gg4 |
ISUP Grade Group 4 (Gleason 4+4 or equivalent) |
| isup-gg5 |
ISUP Grade Group 5 (Gleason 4+5 / 5+4 / 5+5) |
| idc-absent |
Intraductal carcinoma not identified |
| idc-present |
Intraductal carcinoma identifiable |
| cribriform-na |
Cribriform not applicable |
| cribriform-unknown |
Cribriform undefined |
| cribriform-present |
Cribriform identifiable |
| dre-not-done |
DRE not performed |
| dre-normal |
DRE normal |
| dre-suspicious |
DRE suspicious |
| referral-screening |
Referral for screening |
| referral-elevated-psa |
Referral for elevated PSA |
| referral-other |
Other referral reason |
| ynk-yes |
Yes |
| ynk-no |
No |
| ynk-unknown |
Unknown |
| pirads-cat-1-2 |
PI-RADS 1–2 |
| pirads-cat-3 |
PI-RADS 3 |
| pirads-cat-4 |
PI-RADS 4 |
| pirads-cat-5 |
PI-RADS 5 |
| pattern4-pct-na |
Pattern 4 %: not applicable |
| pattern4-pct-lte5 |
Pattern 4 %: ≤5% |
| pattern4-pct-6-10 |
Pattern 4 %: 6–10% |
| pattern4-pct-gt40 |
Pattern 4 %: >40% |
| tumor-pct-lt1 |
Tumour % in biopsy: <1% |
| tumor-pct-1-5 |
Tumour % in biopsy: 1–5% |
| tumor-pct-gt90 |
Tumour % in biopsy: >90% |
| tumor-pct-uneval |
Tumour %: cannot be evaluated |
| periprostatic-unknown |
Periprostatic fat invasion: unidentifiable |
| periprostatic-absent |
Periprostatic fat invasion: not identified |
| periprostatic-present |
Periprostatic fat invasion: present |
| biopsy-initial |
Initial biopsy |
| biopsy-repeat |
Repeat biopsy |
| fixative-buffered-formalin |
10% buffered formalin |
| fixative-unfixed |
Unfixed (no fixative) |
| dx-n40-gph |
N40 Glandular prostatic hyperplasia |
| dx-c61 |
C61 Malignant neoplasm of prostate |
| ct-1c |
cT1c |
| ct-2 |
cT2 |
| ct-3a |
cT3a |
| ct-3b |
cT3b |
| op-transperineal |
Transperineal biopsy |
| op-transrectal |
Transrectal biopsy |
| proc-systematic |
Systematic biopsy |
| proc-adaptive |
Adaptive biopsy |
| proc-systematic-targeted |
Systematic + targeted biopsy |
| proc-applicative-perifocal |
Applicative + perifocal biopsy |
| perineural-present |
Perineural invasion present |
| perineural-absent |
Perineural invasion not identified |
| perineural-ambiguous |
Perineural invasion ambiguous |
| perineural-uneval |
Perineural invasion cannot be evaluated |
| lymphovascular-present |
Lymphovascular invasion identifiable |
| lymphovascular-absent |
Lymphovascular invasion unidentifiable / not available |
| lymphovascular-ambiguous |
Lymphovascular invasion ambiguous |
| lymphovascular-uneval |
Lymphovascular invasion cannot be evaluated |